| 2000 | Humans (MeSH) |
| 1999 | Animals (MeSH) |
| 1888 | Cats (MeSH) |
| 951 | Dogs (MeSH) |
| 512 | Female (MeSH) |
| 397 | Male (MeSH) |
| 260 | Cat Diseases (MeSH) |
| 223 | Cat Diseases (epidemiology) |
| 192 | Adult (MeSH) |
| 172 | Dog Diseases (MeSH) |
| 157 | Pets (MeSH) |
| 139 | Dog Diseases (epidemiology) |
| 132 | Retrospective Studies (MeSH) |
| 127 | Child (MeSH) |
| 121 | Middle Aged (MeSH) |
| 117 | Surveys and Questionnaires (MeSH) |
| 117 | Phylogeny (MeSH) |
| 112 | SARS-CoV-2 (MeSH) |
| 112 | Mice (MeSH) |
| 110 | Seroepidemiologic Studies (MeSH) |
| 109 | COVID-19 (veterinary) |
| 107 | Adolescent (MeSH) |
| 105 | Risk Factors (MeSH) |
| 103 | Cross-Sectional Studies (MeSH) |
| 103 | Cat Diseases (diagnosis) |
| 101 | Prevalence (MeSH) |
| 100 | Aged (MeSH) |
| 98 | Cattle (MeSH) |
| 97 | Young Adult (MeSH) |
| 87 | Cat Diseases (drug therapy) |
| 81 | Swine (MeSH) |
| 80 | COVID-19 (epidemiology) |
| 78 | Child, Preschool (MeSH) |
| 73 | Ownership (MeSH) |
| 70 | Veterinarians (MeSH) |
| 67 | Cat Diseases (microbiology) |
| 63 | COVID-19 (MeSH) |
| 60 | Zoonoses (epidemiology) |
| 60 | Horses (MeSH) |
| 60 | Dog Diseases (diagnosis) |
| 59 | Anti-Bacterial Agents (therapeutic use) |
| 57 | Rats (MeSH) |
| 56 | Pandemics (MeSH) |
| 55 | SARS-CoV-2 (genetics) |
| 52 | Cat Diseases (parasitology) |
| 52 | Brazil (epidemiology) |
| 49 | Toxoplasma (MeSH) |
| 49 | Cat Diseases (virology) |
| 49 | Cat Diseases (therapy) |
| 48 | Pregnancy (MeSH) |
| 46 | Zoonoses (transmission) |
| 46 | Anti-Bacterial Agents (pharmacology) |
| 45 | Prospective Studies (MeSH) |
| 45 | Dog Diseases (parasitology) |
| 45 | Cat Diseases (transmission) |
| 44 | Toxoplasmosis (epidemiology) |
| 44 | Animals, Wild (MeSH) |
| 42 | Infant (MeSH) |
| 42 | Dog Diseases (drug therapy) |
| 41 | Genotype (MeSH) |
| 41 | Dog Diseases (microbiology) |
| 41 | Allergens (MeSH) |
| 39 | Animals, Domestic (MeSH) |
| 39 | Allergens (immunology) |
| 38 | Sheep (MeSH) |
| 38 | Cat Diseases (prevention & control) |
| 36 | Zoonoses (MeSH) |
| 36 | Treatment Outcome (MeSH) |
| 36 | Rabbits (MeSH) |
| 36 | Dog Diseases (prevention & control) |
| 36 | Cat Diseases (diagnostic imaging) |
| 35 | United States (MeSH) |
| 35 | Feces (parasitology) |
| 35 | Antibodies, Viral (MeSH) |
| 35 | Antibodies, Protozoan (MeSH) |
| 33 | Human-Animal Bond (MeSH) |
| 32 | Disease Models, Animal (MeSH) |
| 32 | COVID-19 (virology) |
| 32 | COVID-19 (transmission) |
| 31 | United Kingdom (MeSH) |
| 31 | Pets (microbiology) |
| 31 | Cat Diseases (pathology) |
| 31 | Aged, 80 and over (MeSH) |
| 30 | Dog Diseases (therapy) |
| 30 | Cat Diseases (surgery) |
| 29 | Sporotrichosis (epidemiology) |
| 29 | Hospitals, Animal (MeSH) |
| 27 | Rabies (epidemiology) |
| 27 | Mutation (MeSH) |
| 26 | Sporotrichosis (microbiology) |
| 26 | Public Health (MeSH) |
| 26 | Mammals (MeSH) |
| 26 | Dog Diseases (transmission) |
| 26 | China (epidemiology) |
| 26 | Cat Diseases (etiology) |
| 26 | Case-Control Studies (MeSH) |
| 25 | Zoonoses (parasitology) |
| 25 | One Health (MeSH) |
| 25 | Iran (epidemiology) |
| 25 | Ferrets (MeSH) |
| 25 | Animal Welfare (MeSH) |
| 24 | Sporotrichosis (veterinary) |
| 24 | SARS-CoV-2 (isolation & purification) |
| 24 | Microbial Sensitivity Tests (MeSH) |
| 24 | Incidence (MeSH) |
| 24 | Cats (virology) |
| 24 | Cat Diseases (genetics) |
| 23 | Zoonoses (microbiology) |
| 23 | Sporothrix (MeSH) |
| 23 | Species Specificity (MeSH) |
| 23 | Quality of Life (MeSH) |
| 22 | Goats (MeSH) |
| 22 | Dog Diseases (pathology) |
| 22 | Chickens (MeSH) |
| 22 | COVID-19 (diagnosis) |
| 22 | Brazil (MeSH) |
| 21 | Veterinary Medicine (MeSH) |
| 21 | Toxoplasmosis, Animal (epidemiology) |
| 21 | Sporotrichosis (drug therapy) |
| 21 | Rabies (prevention & control) |
| 21 | Enzyme-Linked Immunosorbent Assay (MeSH) |
| 21 | Dog Diseases (virology) |
| 21 | Diet (veterinary) |
| 21 | Coronavirus Infections (veterinary) |
| 21 | Cohort Studies (MeSH) |
| 20 | Toxoplasma (genetics) |
| 20 | Toxocariasis (epidemiology) |
| 20 | Pandemics (veterinary) |
| 20 | Hypersensitivity (immunology) |
| 20 | HEK293 Cells (MeSH) |
| 20 | Cell Line (MeSH) |
| 20 | Bites and Stings (complications) |
| 20 | Behavior, Animal (MeSH) |
| 20 | Antibodies, Protozoan (blood) |
| 19 | Students (MeSH) |
| 19 | Pets (virology) |
| 19 | Genetic Variation (MeSH) |
| 19 | Ecosystem (MeSH) |
| 19 | Disease Outbreaks (MeSH) |
| 18 | Sporotrichosis (diagnosis) |
| 18 | Sensitivity and Specificity (MeSH) |
| 18 | Reproducibility of Results (MeSH) |
| 18 | Obesity (veterinary) |
| 18 | Immunoglobulin G (MeSH) |
| 18 | Escherichia coli Infections (veterinary) |
| 18 | Escherichia coli (MeSH) |
| 18 | Cats (microbiology) |
| 18 | Cats (genetics) |
| 18 | Bites and Stings (epidemiology) |
| 18 | Antifungal Agents (therapeutic use) |
| 17 | United States (epidemiology) |
| 17 | Sporothrix (isolation & purification) |
| 17 | Infant, Newborn (MeSH) |
| 17 | Immunoglobulin E (immunology) |
| 17 | Cricetinae (MeSH) |
| 17 | Cats (surgery) |
| 17 | Biomarkers (MeSH) |
| 17 | Antiviral Agents (pharmacology) |
| 16 | Zoonoses (virology) |
| 16 | Skin Tests (MeSH) |
| 16 | Rabies (veterinary) |
| 16 | RNA, Viral (genetics) |
| 16 | Prognosis (MeSH) |
| 16 | Pneumonia, Viral (veterinary) |
| 16 | Parasites (MeSH) |
| 16 | Health Knowledge, Attitudes, Practice (MeSH) |
| 16 | Genome, Viral (MeSH) |
| 16 | Chiroptera (virology) |
| 16 | Asthma (epidemiology) |
| 16 | Antibodies, Viral (blood) |
| 15 | United Kingdom (epidemiology) |
| 15 | Thailand (epidemiology) |
| 15 | Spike Glycoprotein, Coronavirus (metabolism) |
| 15 | Phenotype (MeSH) |
| 15 | Pets (psychology) |
| 15 | Pain (veterinary) |
| 15 | Japan (MeSH) |
| 15 | Hypersensitivity (diagnosis) |
| 15 | Feeding Behavior (MeSH) |
| 15 | Feces (MeSH) |
| 15 | Enzyme-Linked Immunosorbent Assay (veterinary) |
| 15 | Education, Veterinary (MeSH) |
| 14 | Veterinarians (psychology) |
| 14 | Toxocara (MeSH) |
| 14 | Staphylococcal Infections (veterinary) |
| 14 | Staphylococcal Infections (microbiology) |
| 14 | Sporothrix (genetics) |
| 14 | RNA, Viral (MeSH) |
| 14 | Protein Binding (MeSH) |
| 14 | Models, Animal (MeSH) |
| 14 | Longitudinal Studies (MeSH) |
| 14 | Immunoglobulin E (blood) |
| 14 | Immunoglobulin E (MeSH) |
| 14 | Host Specificity (MeSH) |
| 14 | Genomics (MeSH) |
| 14 | Feces (microbiology) |
| 14 | Coronavirus Infections (transmission) |
| 14 | Coronavirus Infections (epidemiology) |
| 14 | China (MeSH) |
| 14 | Cat-Scratch Disease (diagnosis) |
| 14 | Cardiomyopathy, Hypertrophic (veterinary) |
| 14 | Angiotensin-Converting Enzyme 2 (metabolism) |
| 14 | Amino Acid Sequence (MeSH) |
| 14 | Algorithms (MeSH) |
| 13 | Zoonoses (prevention & control) |
| 13 | Whole Genome Sequencing (MeSH) |
| 13 | Toxoplasma (immunology) |
| 13 | Toxocariasis (parasitology) |
| 13 | Spain (epidemiology) |
| 13 | Pneumonia, Viral (transmission) |
| 13 | Pasteurella multocida (MeSH) |
| 13 | Neoplasms (veterinary) |
| 13 | Japan (epidemiology) |
| 13 | Immunoglobulin M (MeSH) |
| 13 | Family Characteristics (MeSH) |
| 13 | Dog Diseases (etiology) |
| 13 | Chiroptera (MeSH) |
| 13 | Cats (parasitology) |
| 13 | Carcinoma, Squamous Cell (veterinary) |
| 12 | Spike Glycoprotein, Coronavirus (genetics) |
| 12 | SARS-CoV-2 (immunology) |
| 12 | Polymerase Chain Reaction (MeSH) |
| 12 | Hypersensitivity (therapy) |
| 12 | Evolution, Molecular (MeSH) |
| 12 | Dogs (microbiology) |
| 12 | Dog Diseases (surgery) |
| 12 | Dog Diseases (diagnostic imaging) |
| 12 | Deer (MeSH) |
| 12 | Coronavirus Infections (virology) |
| 12 | Bites and Stings (MeSH) |
| 12 | Bartonella henselae (MeSH) |
| 12 | Attitude (MeSH) |
| 12 | Antibodies, Neutralizing (MeSH) |
| 12 | Animal Feed (MeSH) |
| 11 | Virulence (MeSH) |
| 11 | Vaccination (veterinary) |
| 11 | Toxoplasmosis, Animal (parasitology) |
| 11 | Toxoplasmosis (complications) |
| 11 | Seasons (MeSH) |
| 11 | Renal Insufficiency, Chronic (veterinary) |
| 11 | RNA, Ribosomal, 16S (genetics) |
| 11 | Pilot Projects (MeSH) |
| 11 | Pasteurella Infections (diagnosis) |
| 11 | Ownership (statistics & numerical data) |
| 11 | Ovariectomy (veterinary) |
| 11 | Oocysts (MeSH) |
| 11 | Immunoglobulin G (blood) |
| 11 | Hysterectomy (veterinary) |
| 11 | Hospitals, Teaching (MeSH) |
| 11 | Flea Infestations (veterinary) |
| 11 | Drug Resistance, Bacterial (MeSH) |
| 11 | Dogs (virology) |
| 11 | Dog Diseases (genetics) |
| 11 | Disease Outbreaks (veterinary) |
| 11 | Cats (physiology) |
| 11 | Asthma (immunology) |
| 10 | Social Behavior (MeSH) |
| 10 | SARS-CoV-2 (pathogenicity) |
| 10 | SARS-CoV-2 (classification) |
| 10 | Rabies Vaccines (administration & dosage) |
| 10 | Pneumonia, Viral (epidemiology) |
| 10 | Phlebovirus (genetics) |
| 10 | Pets (immunology) |
| 10 | Multilocus Sequence Typing (MeSH) |
| 10 | Motivation (MeSH) |
| 10 | Mink (MeSH) |
| 10 | Microbial Sensitivity Tests (veterinary) |
| 10 | Leptospirosis (epidemiology) |
| 10 | Hypersensitivity (epidemiology) |
| 10 | Guinea Pigs (MeSH) |
| 10 | Environmental Exposure (adverse effects) |
| 10 | Emotions (MeSH) |
| 10 | Echocardiography (veterinary) |
| 10 | Computer Simulation (MeSH) |
| 10 | Clinical Competence (MeSH) |
| 10 | Cities (MeSH) |
| 10 | Cat Diseases (psychology) |
| 10 | Canada (MeSH) |
| 10 | COVID-19 (prevention & control) |
| 10 | Birds (MeSH) |
| 10 | Australia (MeSH) |
| 9 | Zoonoses (diagnosis) |
| 9 | Toxoplasmosis (diagnosis) |
| 9 | Skin Neoplasms (veterinary) |
| 9 | Skin (pathology) |
| 9 | Real-Time Polymerase Chain Reaction (veterinary) |
| 9 | Pneumonia, Viral (virology) |
| 9 | Pasteurella Infections (drug therapy) |
| 9 | New York (MeSH) |
| 9 | Mink (virology) |
| 9 | Mental Health (MeSH) |
| 9 | Leukemia Virus, Feline (genetics) |
| 9 | Itraconazole (therapeutic use) |
| 9 | Insect Vectors (parasitology) |
| 9 | Hypersensitivity (MeSH) |
| 9 | Hepadnaviridae (genetics) |
| 9 | Germany (epidemiology) |
| 9 | Ferrets (virology) |
| 9 | Farms (MeSH) |
| 9 | Europe (MeSH) |
| 9 | Enzyme-Linked Immunosorbent Assay (methods) |
| 9 | DNA, Protozoan (genetics) |
| 9 | Cats (immunology) |
| 9 | Cat-Scratch Disease (drug therapy) |
| 9 | Cat Diseases (immunology) |
| 9 | Bartonella Infections (veterinary) |
| 9 | Bartonella Infections (epidemiology) |
| 9 | Bartonella (genetics) |
| 9 | Asthma (diagnosis) |
| 9 | Antifungal Agents (pharmacology) |
| 9 | Angiotensin-Converting Enzyme 2 (genetics) |
| 9 | Age Factors (MeSH) |
| 8 | beta-Lactamases (genetics) |
| 8 | Virus Shedding (MeSH) |
| 8 | Vero Cells (MeSH) |
| 8 | Ultrasonography (veterinary) |
| 8 | Toxoplasmosis (parasitology) |
| 8 | Tomography, X-Ray Computed (MeSH) |
| 8 | Tinea (veterinary) |
| 8 | Staphylococcus (MeSH) |
| 8 | Staphylococcal Infections (epidemiology) |
| 8 | Sporothrix (classification) |
| 8 | Sequence Alignment (MeSH) |
| 8 | Seizures (veterinary) |
| 8 | Rhinitis, Allergic (epidemiology) |
| 8 | RNA (MeSH) |
| 8 | Pregnant Women (MeSH) |
| 8 | Pregnancy Complications, Parasitic (epidemiology) |
| 8 | Post-Exposure Prophylaxis (MeSH) |
| 8 | Poland (epidemiology) |
| 8 | Orthomyxoviridae Infections (veterinary) |
| 8 | New Zealand (MeSH) |
| 8 | Models, Molecular (MeSH) |
| 8 | Methicillin-Resistant Staphylococcus aureus (MeSH) |
| 8 | Leukemia Virus, Feline (MeSH) |
| 8 | Leishmaniasis, Visceral (veterinary) |
| 8 | Inflammation (veterinary) |
| 8 | Immunoglobulin M (blood) |
| 8 | Immunodeficiency Virus, Feline (genetics) |
| 8 | Immunodeficiency Virus, Feline (MeSH) |
| 8 | Genetic Predisposition to Disease (MeSH) |
| 8 | Epilepsy (veterinary) |
| 8 | Dogs (parasitology) |
| 8 | DNA (MeSH) |
| 8 | Communication (MeSH) |
| 8 | Chlorocebus aethiops (MeSH) |
| 8 | Cat Diseases (metabolism) |
| 8 | Cat Diseases (chemically induced) |
| 8 | Cat Diseases (blood) |
| 8 | Castration (veterinary) |
| 8 | Capnocytophaga (MeSH) |
| 8 | Calicivirus, Feline (MeSH) |
| 8 | COVID-19 (immunology) |
| 8 | Bunyaviridae Infections (veterinary) |
| 8 | Breast Neoplasms (pathology) |
| 8 | Bacteria (genetics) |
| 8 | Anti-Infective Agents (therapeutic use) |
| 8 | Anti-Infective Agents (MeSH) |
| 8 | Animal Feed (analysis) |
| 8 | Anesthesia (veterinary) |
| 7 | Virulence Factors (genetics) |
| 7 | Turkey (epidemiology) |
| 7 | Toxoplasmosis (MeSH) |
| 7 | Toxocara canis (MeSH) |
| 7 | Temperature (MeSH) |
| 7 | Sporotrichosis (transmission) |
| 7 | Spike Glycoprotein, Coronavirus (chemistry) |
| 7 | Soil (parasitology) |
| 7 | Signal Transduction (MeSH) |
| 7 | Severe Fever with Thrombocytopenia Syndrome (veterinary) |
| 7 | Sequence Analysis, DNA (MeSH) |
| 7 | Self Report (MeSH) |
| 7 | SARS-CoV-2 (physiology) |
| 7 | Rural Population (MeSH) |
| 7 | Registries (MeSH) |
| 7 | Receptors, Virus (metabolism) |
| 7 | Rabies Vaccines (MeSH) |
| 7 | Rabies (transmission) |
| 7 | Protozoan Proteins (genetics) |
| 7 | Perception (MeSH) |
| 7 | Peptidyl-Dipeptidase A (metabolism) |
| 7 | Parasitic Diseases, Animal (epidemiology) |
| 7 | Pandemics (prevention & control) |
| 7 | Pain Measurement (veterinary) |
| 7 | Orthomyxoviridae Infections (epidemiology) |
| 7 | Molecular Docking Simulation (MeSH) |
| 7 | Mammals (genetics) |
| 7 | Malaysia (epidemiology) |
| 7 | Leptospirosis (veterinary) |
| 7 | Larva (MeSH) |
| 7 | Italy (epidemiology) |
| 7 | Immunohistochemistry (MeSH) |
| 7 | Hyperthyroidism (veterinary) |
| 7 | Glycoproteins (immunology) |
| 7 | Germany (MeSH) |
| 7 | Genome, Bacterial (MeSH) |
| 7 | Gene Expression (MeSH) |
| 7 | Foxes (MeSH) |
| 7 | Follow-Up Studies (MeSH) |
| 7 | Felis (MeSH) |
| 7 | Escherichia coli Infections (microbiology) |
| 7 | Dust (MeSH) |
| 7 | Disease Susceptibility (MeSH) |
| 7 | Diagnosis, Differential (MeSH) |
| 7 | Cues (MeSH) |
| 7 | Ctenocephalides (microbiology) |
| 7 | Cross Reactions (MeSH) |
| 7 | Creatinine (MeSH) |
| 7 | Coronavirus, Feline (MeSH) |
| 7 | Coronavirus Infections (prevention & control) |
| 7 | Colombia (epidemiology) |
| 7 | Coinfection (epidemiology) |
| 7 | Cell Line, Tumor (MeSH) |
| 7 | Cell Differentiation (MeSH) |
| 7 | Cat-Scratch Disease (complications) |
| 7 | COVID-19 Vaccines (MeSH) |
| 7 | Brain (MeSH) |
| 7 | Blood Donors (MeSH) |
| 7 | Bartonella henselae (isolation & purification) |
| 7 | Antibodies, Neutralizing (immunology) |
| 7 | Animal Technicians (MeSH) |
| 7 | Angiotensin-Converting Enzyme 2 (MeSH) |
| 6 | Virus Replication (MeSH) |
| 6 | Viral Tropism (MeSH) |
| 6 | Tinea (diagnosis) |
| 6 | Time Factors (MeSH) |
| 6 | Ticks (microbiology) |
| 6 | Tick Infestations (veterinary) |
| 6 | Thailand (MeSH) |
| 6 | Sus scrofa (MeSH) |
| 6 | Staphylococcus aureus (MeSH) |
| 6 | South Africa (epidemiology) |
| 6 | Schools (MeSH) |
| 6 | SARS-CoV-2 (metabolism) |
| 6 | Rotavirus (genetics) |
| 6 | Risk Assessment (MeSH) |
| 6 | Rhinitis, Allergic (immunology) |
| 6 | Raccoons (MeSH) |
| 6 | Proteomics (MeSH) |
| 6 | Protein Domains (MeSH) |
| 6 | Pneumonia, Viral (prevention & control) |
| 6 | Phlebovirus (isolation & purification) |
| 6 | Pets (parasitology) |
| 6 | Pain Management (veterinary) |
| 6 | Pain (diagnosis) |
| 6 | Opisthorchiasis (epidemiology) |
| 6 | Odds Ratio (MeSH) |
| 6 | Obesity (prevention & control) |
| 6 | Netherlands (epidemiology) |
| 6 | Molecular Dynamics Simulation (MeSH) |
| 6 | Models, Biological (MeSH) |
| 6 | Microsporum (MeSH) |
| 6 | Microbiota (MeSH) |
| 6 | Mice, Inbred C57BL (MeSH) |
| 6 | Mexico (epidemiology) |
| 6 | Magnetic Resonance Imaging (veterinary) |
| 6 | Magnetic Resonance Imaging (MeSH) |
| 6 | Macaca (MeSH) |
| 6 | Lynx (MeSH) |
| 6 | Liver (metabolism) |
| 6 | Leukemia, Feline (MeSH) |
| 6 | Ixodes (MeSH) |
| 6 | Intestinal Diseases, Parasitic (veterinary) |
| 6 | Influenza, Human (MeSH) |
| 6 | India (epidemiology) |
| 6 | Hypersensitivity (etiology) |
| 6 | Housing (MeSH) |
| 6 | Glycoproteins (MeSH) |
| 6 | Giardiasis (veterinary) |
| 6 | Giardia lamblia (genetics) |
| 6 | Gene Expression Regulation (MeSH) |
| 6 | Friends (MeSH) |
| 6 | Food Hypersensitivity (immunology) |
| 6 | Flea Infestations (epidemiology) |
| 6 | Escherichia coli Infections (epidemiology) |
| 6 | Environmental Exposure (MeSH) |
| 6 | Endocarditis, Bacterial (microbiology) |
| 6 | Drug Resistance, Multiple, Bacterial (MeSH) |
| 6 | Drug Resistance, Bacterial (genetics) |
| 6 | Double-Blind Method (MeSH) |
| 6 | Diarrhea (veterinary) |
| 6 | Desensitization, Immunologic (methods) |
| 6 | Dander (immunology) |
| 6 | Chagas Disease (veterinary) |
| 6 | Cells, Cultured (MeSH) |
| 6 | Cattle Diseases (MeSH) |
| 6 | Cardiomyopathy, Hypertrophic (genetics) |
| 6 | Carcinoma, Squamous Cell (pathology) |
| 6 | CRISPR-Cas Systems (MeSH) |
| 6 | Bites and Stings (virology) |
| 6 | Betacoronavirus (pathogenicity) |
| 6 | Betacoronavirus (genetics) |
| 6 | Betacoronavirus (MeSH) |
| 6 | Behavior, Animal (physiology) |
| 6 | Bartonella henselae (genetics) |
| 6 | Bartonella (MeSH) |
| 6 | Antibodies, Monoclonal (immunology) |
| 6 | Animals, Wild (parasitology) |
| 6 | Animal Husbandry (MeSH) |
| 6 | Angiotensin-Converting Enzyme 2 (chemistry) |
